Takahiro Yoshioka

Takahiro Yoshioka

National Cancer Center - Tokyo / Japan
Medical and Health Sciences / General Surgery
AD Scientific Index ID: 4976465
国立がん研究センター
person_outline Takahiro Yoshioka's MOST POPULAR ARTICLES
1-) Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non–Small Cell Lung Cancer CellsResistance Mechanisms Against … K Namba, K Shien, Y Takahashi, H Torigoe, H Sato, T Yoshioka, ... Molecular Cancer Research 17 (2), 499-507, 2019 582019
2-) Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer H Sato, H Yamamoto, M Sakaguchi, K Shien, S Tomida, T Shien, H Ikeda, ... Cancer Science 109 (10), 3183-3196, 2018 462018
3-) Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer T Takeda, H Yamamoto, H Kanzaki, K Suzawa, T Yoshioka, S Tomida, ... PLoS One 12 (2), e0171356, 2017 292017
4-) Antitumor activity of pan‐HER inhibitors in HER 2‐positive gastric cancerT Yoshioka, K Shien, K Namba, H Torigoe, H Sato, S Tomida, ...Cancer Science 109 (4), 1166-1176, 2018402018
5-) Acquired resistance mechanisms to afatinib in HER2‐amplified gastric cancer cellsT Yoshioka, K Shien, T Takeda, Y Takahashi, E Kurihara, Y Ogoshi, ...Cancer science 110 (8), 2549-2557, 2019332019